文献速递流行病学与生物统计

质疑相对危险度在临床研究中的效用:比值比在荟萃分析中是否「可移植」?

Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio "portable" in meta-analysis? Time to consider bivariate generalized linear mixed model.
PubMed 文献 · J Clin Epidemiol · 2021-08-09

该文针对Doi等人主张用比值比(OR)完全替代相对危险度(RR)的观点提出质疑。作者汇总Cochrane系统评价数据库中40,243项荟萃分析,发现研究特异的OR与基线风险常呈负相关,条件效应随基线风险变化,故认为目前用OR替代RR或危险差(RD)并不可取,建议用双变量广义线性混合模型呈现条件效应。

要点

  • 多数荟萃分析中研究特异的OR与基线风险呈负相关,OR并非「可移植」。
  • 用OR替代RR或RD在临床试验和荟萃分析中目前不可取。
  • 建议用双变量广义线性混合模型基于基线风险呈现条件效应。

核心结论

  • 目前不建议在临床试验和荟萃分析中用OR替代RR或RD。
  • 可能没有任何效应量在荟萃分析中是「可移植」的。
  • 除总体(边际)效应外,建议基于基线风险用双变量广义线性混合模型呈现条件效应。

研究设计与样本

  • 本文为争议与辩论类文章,汇总Cochrane系统评价数据库中40,243项荟萃分析。
  • 计算研究特异OR与基线风险的Spearman秩相关系数。
  • 使用一个实际荟萃分析示例展示OR、RR或RD与基线风险的负相关及条件效应变化。

主要发现

  • 在Cochrane系统评价数据库的大多数荟萃分析中,研究特异的OR在基线疾病风险较低的研究中倾向于更高。
  • 实际荟萃分析示例显示OR、RR或RD与基线风险呈强负相关,条件效应随基线风险显著变化。

临床怎么用

  • 临床试验与荟萃分析报告效应量时不应简单用OR替代RR或RD。
  • 应同时报告总体(边际)效应和基于基线风险的条件效应。
  • 条件效应可用双变量广义线性混合模型估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: A recent paper by Doi et al. advocated completely replacing the relative risk (RR) with the odds ratio (OR) as the effect measure in clinical trials and meta-analyses with binary outcomes. Besides some practical advantages of RR over OR, Doi et al.'s key assumption that the OR is "portable" in the meta-analysis, that is, study-specific ORs are likely not correlated with baseline risks, was not well justified. STUDY DESIGNS AND SETTINGS: We summarized Spearman's rank correlation coefficient between study-specific ORs and baseline risks in 40,243 meta-analyses from the Cochrane Database of Systematic Reviews. RESULTS: Study-specific ORs tend to be higher in studies with lower baseline risks of disease for most meta-analyses in Cochrane Database of Systematic Reviews. Using an actual meta-analysis example, we demonstrate that there is a strong negative correlation between OR (RR or RD) with the baseline risk and the conditional effects notably vary with baseline risks. CONCLUSIONS: Replacing RR or RD with OR is currently unadvisable in clinical trials and meta-analyses. It is possible that no effect measure is "portable" in a meta-analysis. In addition to the overall (or marginal) effect, we suggest presenting the conditional effect based on the baseline risk using a bivariate generalized linear mixed model.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Xiao M, Chen Y, Cole SR, et al. Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio "portable" in meta-analysis? Time to consider bivariate generalized linear mixed model. J Clin Epidemiol. 2021. PMID: 34384876. doi:10.1016/j.jclinepi.2021.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。